SCHEMBL28296522

SCHEMBL28296522

Clc1cccc(-c2nncc3ccccc23)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ADORA2A P29274 4/20 0.48
▸ ADORA1 P30542 4/20 0.48
▸ SMN1; SMN2 Q16637 4/20 0.43
▸ KDM4E B2RXH2 3/20 0.43
▸ ALDH1A1 P00352 2/20 0.43
▸ CYP1A2 P05177 2/20 0.43
▸ CYP3A4 P08684 2/20 0.43
▸ CYP2D6 P10635 2/20 0.43
▸ MAPT P10636 2/20 0.43
▸ PDE5A O76074 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ HPGD P15428 1/20 0.43
▸ ALOX15 P16050 1/20 0.43
▸ CYP2C19 P33261 1/20 0.43
▸ PDE1A P54750 1/20 0.43
▸ PDE1B Q01064 1/20 0.43
▸ PDE3B Q13370 1/20 0.43
▸ PDE1C Q14123 1/20 0.43
▸ PDE3A Q14432 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28957874 0.83 KDM4E (0.42) SMN1; SMN2KDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL27973695 0.81 LMNA (0.46) SMN1; SMN2KDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL1268508 0.81 KDM4E (0.48) ADORA2AADORA1SMN1; SMN2KDM4EALDH1A1
SCHEMBL29816494 0.81 KDM4E (0.48) ADORA2AADORA1SMN1; SMN2KDM4EALDH1A1
SCHEMBL28657632 0.79 KDM4E (0.47) ADORA2AADORA1SMN1; SMN2KDM4EALDH1A1
SCHEMBL9375509 0.77 PDE4D (0.51) ADORA2AADORA1MAPTPDE3BPDE3A
SCHEMBL27830129 0.77 ADORA2A (0.51) ADORA2AADORA1ALDH1A1CYP1A2MAPT
SCHEMBL29351937 0.77 ADORA2A (0.50) ADORA2AADORA1SMN1; SMN2KDM4EALDH1A1
SCHEMBL27966677 0.77 PDK1 (0.41) SMN1; SMN2KDM4EALDH1A1CYP1A2CYP3A4
SCHEMBL220249 0.77 GRM5 (0.42) SMN1; SMN2KDM4EALDH1A1CYP1A2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-105307655-B Pyridazinone compound and its be used to prepare treatment tumour shape fibrosis drug application 弗拉特利发现实验室有限责任公司 2019-05-03 — — CN disclosed
Send feedback